Fulfilling global healthcare demand with disruptive blood propofol monitors.
Somnus has invented and filed patents for novel propofol sensors that work in real-time at clinically relevant concentrations. Patents cover electrochemical, displacer and propofol antibody inventions. An immunoassay for rapid, near patient testing is being developed and tested in UK hospitals prior to planned market launch in 2026
Read more